CA2204669A1 - Nouvelles molecules d'acide nucleique comportant un antigene prostatique specifique et leurs usages - Google Patents

Nouvelles molecules d'acide nucleique comportant un antigene prostatique specifique et leurs usages

Info

Publication number
CA2204669A1
CA2204669A1 CA 2204669 CA2204669A CA2204669A1 CA 2204669 A1 CA2204669 A1 CA 2204669A1 CA 2204669 CA2204669 CA 2204669 CA 2204669 A CA2204669 A CA 2204669A CA 2204669 A1 CA2204669 A1 CA 2204669A1
Authority
CA
Canada
Prior art keywords
nucleic acid
acid molecule
promoter
gene
psa
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2204669
Other languages
English (en)
Inventor
Shen Pang
Arie S Belldegrun
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/522,841 external-priority patent/US5919652A/en
Application filed by Individual filed Critical Individual
Publication of CA2204669A1 publication Critical patent/CA2204669A1/fr
Abandoned legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La présente invention fournit des molécules d'acide nucléique isolées ou purifiées comportant un promoteur d'un antigène prostatique spécifique seul ou associé à un promoteur de cytomégalovirus.
CA 2204669 1994-11-09 1995-11-07 Nouvelles molecules d'acide nucleique comportant un antigene prostatique specifique et leurs usages Abandoned CA2204669A1 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US33641094A 1994-11-09 1994-11-09
US336,410 1994-11-09
US522,841 1995-09-01
US08/522,841 US5919652A (en) 1994-11-09 1995-09-01 Nucleic acid molecules comprising the prostate specific antigen (PSA) promoter and uses thereof
PCT/US1995/014461 WO1996014875A1 (fr) 1994-11-09 1995-11-07 Nouvelles molecules d'acide nucleique comportant un antigene prostatique specifique et leurs usages

Publications (1)

Publication Number Publication Date
CA2204669A1 true CA2204669A1 (fr) 1996-05-23

Family

ID=29407629

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2204669 Abandoned CA2204669A1 (fr) 1994-11-09 1995-11-07 Nouvelles molecules d'acide nucleique comportant un antigene prostatique specifique et leurs usages

Country Status (1)

Country Link
CA (1) CA2204669A1 (fr)

Similar Documents

Publication Publication Date Title
AU715526B2 (en) Novel nucleic acid molecules comprising the prostate specific antigen (PSA) promoter and uses thereof
WO1996014875A9 (fr) Nouvelles molecules d'acide nucleique comportant un antigene prostatique specifique et leurs usages
Herz et al. Adenovirus-mediated transfer of low density lipoprotein receptor gene acutely accelerates cholesterol clearance in normal mice.
US6737523B1 (en) Nucleic acids comprising regions of the rat PEG-3 promoter that display elevated expression in human cancer cells and uses thereof
US6555674B2 (en) JeT promoter
US5635380A (en) Enhancement of nucleic acid transfer by coupling virus to nucleic acid via lipids
US5993800A (en) Methods for prolonging the expression of a heterologous gene of interest using soluble CTLA4 molecules and an antiCD40 ligand
JP2008301832A (ja) インターフェロン−α核酸の送達および発現のための方法および組成物
JP4386971B2 (ja) スプライシング配列を含んでなる組換えアデノウイルスベクター
US6503498B1 (en) Apolipoprotein A-1 adenovirus vector compositions and methods
US6110702A (en) PSA positive regulating (PSAR) sequences and uses thereof
CA2204669A1 (fr) Nouvelles molecules d'acide nucleique comportant un antigene prostatique specifique et leurs usages
WO1997035993A9 (fr) Sequences de regulation positive de l'antigene prostatique specifique et utilisations de ces sequences
US6841362B1 (en) Melanoma differentiation associated gene-7 promoter and uses thereof
AU2002237910B2 (en) Method of enhancing delivery of a therapeutic nucleic acid
Eslahi et al. Fusogenic activity of vesicular stomatitis virus glycoprotein plasmid in tumors as an enhancer of IL-12 gene therapy
JP2004520006A (ja) ラットｐｅｇ−３プロモーターの領域を含んでなる核酸とその利用
EP0832227B1 (fr) Procede de prolongation de l'expression d'un gene d'interet a l'aide de molecules ctla4 solubles
US6982148B2 (en) Progressive elevated gene-3 (PEG-3) induces aggressive cancer phenotype and regulates angiogenesis
AU2002237910A1 (en) Method of enhancing delivery of a therapeutic nucleic acid
Strayer Novel vectors for gene therapy
Wei Establishment and application of an embryonic yolk sac cell-derived mini-organ gene delivery system for gene therapy
EP1829555A2 (fr) Procédé d'amélioration de distribution d'acide nucléique thérapeutique

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead